Following Ujjivan’s earnings, several top brokerages recommended a ‘Buy’ stance on the counter. While Emkay retained its buy rating on for a target price of Rs 58, HDFC Securities has an ‘Add’ recommendation for a target of Rs 50. ICICI Securities was most bullish in terms of targets and pegged it at Rs 60.
Global Health Q2 Results: Medanta operator posts 5% rise in net profit YoY at Rs 131 crore
Global Health, which operates hospitals under the Medanta brand, on Thursday said its profit after tax increased 5 per cent to Rs 131 crore in
November 14, 2024